Table 4 |
||||||||
|
Details of patients positive by TaqMan assay |
||||||||
|
Patient |
Age(yr) |
Sex |
MATa |
MAT |
Serovar |
ELISAb |
Culture |
CT (Average) |
|
|
||||||||
|
A |
60 |
M |
ND (10/7/01) |
400 (20/7/01) |
hardjo |
NT |
+ |
37.75 |
|
B |
35 |
M |
ND (2/3/01) |
800 (16/3/01) |
tarassovi |
ND |
+ |
36.03 |
|
C |
48 |
M |
ND (14/5/01) |
200 (16/5/01) |
pomona |
NT |
NT |
38.44 |
|
D |
28 |
M |
NT |
NT |
zanoni |
ND |
+ |
39.87 |
|
|
||||||||
|
aMicroscopic agglutination tests (date of collection) bEnzyme linked immunosorbent assay NT: Not Tested ND: Not Detected |
||||||||
|
Smythe et al. BMC Infectious Diseases 2002 2:13 doi:10.1186/1471-2334-2-13 |
||||||||
